Test, Cell Mediated Immune Response, Liver And Small Bowel Transplant/Transplantation
PHK is the FDA product code for Test, Cell Mediated Immune Response, Liver And Small Bowel Transplant/Transplantation. FDA's definition for this code reads: "The test is a qualitative prognostic test intended to be used in patients less than 21 years old with liver or small bowel transplantation. The test is an aid in the evaluation of the risk of acute cellular rejection (ACR) and must be used in conjunction with biopsy, standard clinical assessment and other laboratory...". As of , FDA records hold no 510(k) clearances under this code and no recalls.
Classification record
- Product code
- PHK
- Device name
- Test, Cell Mediated Immune Response, Liver And Small Bowel Transplant/Transplantation
- FDA definition
- The test is a qualitative prognostic test intended to be used in patients less than 21 years old with liver or small bowel transplantation. The test is an aid in the evaluation of the risk of acute cellular rejection (ACR) and must be used in conjunction with biopsy, standard clinical assessment and other laboratory information.
- Device class
- Not classified
- Review panel
- Unknown
- Submission type
- FDA code 6
- Implant
- No
- Life sustaining or supporting
- No
- GMP exempt
- No
- Third party review eligible
- No
- Ingested clearances
- 0
- Ingested recalls
- 0
Companies listing this code with FDA
Companies whose registered establishments list this codeFIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
